Skip to main content

SBC Medical Group Holdings Inc

For the period ended Sep 30, 2025. Filed Nov 14, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 14, 2025

SBC$5.29+0.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unregistered Sales of Equity Securities and Use of Proceeds

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

During the three months ended September 30, 2025, we purchased common stock as set forth below:

Period · Total Numberof SharesPurchased · Average PricePaid per Share · Total Numberof SharesPurchased as Part of Publicly AnnouncedPlans or Programs · ApproximateDollar Valueof SharesThat May Yet BePurchased Under thePlans or Programs
(in millions)
July 1, 2025 – July 31, 2025521,499$5.00521,499$—
August 1, 2025 – August 31, 2025————
September 1, 2025 – September 30, 2025————
Total521,499521,499

On May 15, 2025, the Company announced the initiation of a share repurchase program for up to $5 million in shares of common stock for the period from May 20, 2025 through May 20, 2026. The Board of Directors authorized repurchases in open market transactions, including under a Rule 10b5-1 trading plan and in accordance with Rule 10b-18 under the Exchange Act. All share repurchases set forth above were made using cash resources. On July 22, 2025, the Company completed its previously announced share repurchase program. Under the program, the Company repurchased an aggregate of 1,034,308 shares of its common stock for a total cash consideration of approximately $5 million, exhausting the full authorization.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.